The depression drugs market, valued at over US$ 6.5 billion in 2017, is likely to witness bearishness in the near future, with a new report by Fact.MR estimating revenues to decline at a -2% CAGR. According to the study, although the prevalence rate of depression has gone up in the last decade, preference for cognitive behavior therapy (CBT) and awareness about the potential side effects has led to a decline in demand for depression drugs. The study finds that US continued to be at the forefront in terms of total depression drugs sold in 2018.
For detailed insights on enhancing your product footprint, request a sample here- https://www.factmr.com/connectus/sample?flag=S&rep_id=3215
According to the World Health Organization (WHO), depression has become one of the common illnesses, affecting over 300 million people across the world. In the United States, approximately 10.3 million adults had experienced at least one major depressive episode that resulted in severe impairment, according to the National Institute of Mental Health (NIMH). High prevalence of such depressive episode was observed among people aged 18-25 (10.9%), female adults (8.5%), and male adults (4.8%). According to the Fact.MR study, although depression continues to be a major health issue, medical community and patients are encouraging a non-drug approach to reduce side effects and dependency. Healthcare providers and patients are focusing on cognitive behavior therapy (CBT) and mindfulness-based approaches to foster a long-term management of depression and other mental health issues.
The study finds that demand for depression drugs is also witnessing a decline as end-users have more coping options at their disposal. The huge popularity of mental health apps, such as Headspace, Calm, Moodnotes, Pacifica, and SuperBetter has given patients more control over how they manage depression. Considering the growing body of research supporting the use of meditation and cognitive behavior therapy, the proliferation of tech apps has witnessed a spike in the recent years. The study finds that depression drugs market will continue to be influenced by these evolutions.
For comprehensive insights on this market adoption, ask an analyst here- https://www.factmr.com/connectus/sample?flag=AE&rep_id=3215
North America and Europe are the two largest depression drugs market globally, owing to concentration of leading market players and increase in R&D of these drugs. While there has been a rising burden of mental illness such as bipolar I disorder and schizophrenia in China and India, lack of wide-ranging awareness regarding antidepressant medications (ADMs) is expected to negatively affect the growth of depression drugs market in the Asia Pacific region. Moreover, different therapies of depression are as efficacious as ADM and their effects are more enduring, which may create a hindrance in future expansion of depression drugs market, especially in Asia Pacific and Middle East & Africa.
For More Insights https://www.newswire.co.kr/newsRead.php?no=923083
Some key players operating in the manufacturing of depression drugs are
Teva Pharmaceutical Industries Ltd.
For in-depth competitive analysis, buy now – https://www.factmr.com/checkout/3215
About Us:
Market research and consulting agency with a difference! That’s why 80% of Fortune 1,000 companies trust us for making their most critical decisions. While our experienced consultants employ the latest technologies to extract hard-to-find insights, we believe our USP is the trust clients have on our expertise. Spanning a wide range – from automotive & industry 4.0 to healthcare & retail, our coverage is expansive, but we ensure even the most niche categories are analyzed. Our sales offices in United States and Dublin, Ireland. Headquarter based in Dubai, UAE. Reach out to us with your goals, and we’ll be an able research partner.
Contact:
Written By
Head Guards Market research Report is an inestimable supply of insightful data for business strategists. This Head Guards Market study provides extensive data which enlarge the understanding, scope, and application of this report. A specified study of the competitive landscape of the global Head Guards Market has allow, providing insights into the corporate profiles, financial position, recent ...
Global extremities reconstruction market to register a significant CAGR growth of 6.1% over the forecast period 2017 to 2022. Revenues from the global market for extremities reconstruction are expected to exceed US$ 2,000 Million by 2022-end. With the growin...
The report offers insight into the Competitive Dynamic in Biobanking Equipment Market which has shaped the major strategies of each player. It also covers recent moves such as partnerships and collaborations, mergers and acquisitions, diversification and research i...
According to the recent research by Fact MR, the endoscope cleaning products market is anticipated to witness 7.8% growth during the forecast period from 2021 to 2031. This noteworthy growth will be experienced due to the high prevalence of endoscopic-related inf...